View in EDS HTML Full Text PDF Full Text

Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk.

Saved in:
Bibliographic Details
Title: Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk.
Authors: Richard S; Icahn School of Medicine at Mount Sinai Tisch Cancer Institute, New York, New York, USA., Chari A; Icahn School of Medicine at Mount Sinai Tisch Cancer Institute, New York, New York, USA., Delimpasi S; General Hospital Evangelismos, Athens, Greece., Simonova M; Institute of Blood Pathology & Transfusion Medicine of National Academy of Medical Sciences of Ukraine, Lviv, Ukraine., Spicka I; Charles University and General Hospital, Prague, Czech Republic., Pour L; Clinic of Internal Medicine -Hematology and Oncology, University Hospital Brno, Brno, Czech Republic., Kriachok I; National Cancer Institute Ukraine, Kiev, Ukraine., Dimopoulos MA; School of Medicine, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Pylypenko H; Department of Hematology, Cherkassy Regional Oncological Center, Cherkassy, Ukraine., Auner HW; Imperial College London, London, UK., Leleu X; Department of Hematology, CHU la Miletrie and Inserm CIC 1402, Poitiers, France., Usenko G; City Clinical Hospital No. 4 of Dnipro City Council, Dnipro, Ukraine., Hajek R; Department of Hemato-oncology, University Hospital Ostrava, University of Ostrava, Ostrava, Czech Republic., Benjamin R; Kings College Hospital NHS Foundation Trust, London, UK., Dolai TK; Nil Ratan Sircar Medical College and Hospital, Kolkata, India., Sinha DK; State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, India., Venner CP; Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Garg M; University Hospitals of Leicester NHS Trust, Leicester, UK., Stevens DA; Norton Cancer Institute, St. Matthews Campus, Louisville, Kentucky, USA., Quach H; University of Melbourne, St. Vincent's Hospital, Melbourne, Victoria, Australia., Jagannath S; Icahn School of Medicine at Mount Sinai Tisch Cancer Institute, New York, New York, USA., Moreau P; University Hospital, Hotel-Dieu, Nantes, France., Levy M; Baylor University Medical Center, Dallas, Texas, USA., Badros A; University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA., Anderson LD Jr; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA., Bahlis NJ; University of Calgary, Charbonneau Cancer Research Institute, Calgary, Alberta, Canada., Facon T; CHU Lille Service des Maladies du Sang F-59000, Lille, France., Mateos MV; Hospital Universitario de Salamanca, Salamanca, Spain., Cavo M; Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy., Chang H; Karyopharm Therapeutics Inc., Newton, Massachusetts, USA., Landesman Y; Karyopharm Therapeutics Inc., Newton, Massachusetts, USA., Chai Y; Karyopharm Therapeutics Inc., Newton, Massachusetts, USA., Arazy M; Karyopharm Therapeutics Inc., Newton, Massachusetts, USA., Shah J; Karyopharm Therapeutics Inc., Newton, Massachusetts, USA., Shacham S; Karyopharm Therapeutics Inc., Newton, Massachusetts, USA., Kauffman MG; Karyopharm Therapeutics Inc., Newton, Massachusetts, USA., Grosicki S; Medical University of Silesia, Katowice, Poland., Richardson PG; Dana Farber Cancer Institute, Boston, Massachusetts, USA.
Source: American journal of hematology [Am J Hematol] 2021 Sep 01; Vol. 96 (9), pp. 1120-1130. Date of Electronic Publication: 2021 Jul 05.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34062004
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Richard+S%22">Richard S</searchLink>; Icahn School of Medicine at Mount Sinai Tisch Cancer Institute, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Chari+A%22">Chari A</searchLink>; Icahn School of Medicine at Mount Sinai Tisch Cancer Institute, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Delimpasi+S%22">Delimpasi S</searchLink>; General Hospital Evangelismos, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Simonova+M%22">Simonova M</searchLink>; Institute of Blood Pathology & Transfusion Medicine of National Academy of Medical Sciences of Ukraine, Lviv, Ukraine.<br /><searchLink fieldCode="AU" term="%22Spicka+I%22">Spicka I</searchLink>; Charles University and General Hospital, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Pour+L%22">Pour L</searchLink>; Clinic of Internal Medicine -Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Kriachok+I%22">Kriachok I</searchLink>; National Cancer Institute Ukraine, Kiev, Ukraine.<br /><searchLink fieldCode="AU" term="%22Dimopoulos+MA%22">Dimopoulos MA</searchLink>; School of Medicine, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Pylypenko+H%22">Pylypenko H</searchLink>; Department of Hematology, Cherkassy Regional Oncological Center, Cherkassy, Ukraine.<br /><searchLink fieldCode="AU" term="%22Auner+HW%22">Auner HW</searchLink>; Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Leleu+X%22">Leleu X</searchLink>; Department of Hematology, CHU la Miletrie and Inserm CIC 1402, Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Usenko+G%22">Usenko G</searchLink>; City Clinical Hospital No. 4 of Dnipro City Council, Dnipro, Ukraine.<br /><searchLink fieldCode="AU" term="%22Hajek+R%22">Hajek R</searchLink>; Department of Hemato-oncology, University Hospital Ostrava, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Benjamin+R%22">Benjamin R</searchLink>; Kings College Hospital NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Dolai+TK%22">Dolai TK</searchLink>; Nil Ratan Sircar Medical College and Hospital, Kolkata, India.<br /><searchLink fieldCode="AU" term="%22Sinha+DK%22">Sinha DK</searchLink>; State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, India.<br /><searchLink fieldCode="AU" term="%22Venner+CP%22">Venner CP</searchLink>; Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Garg+M%22">Garg M</searchLink>; University Hospitals of Leicester NHS Trust, Leicester, UK.<br /><searchLink fieldCode="AU" term="%22Stevens+DA%22">Stevens DA</searchLink>; Norton Cancer Institute, St. Matthews Campus, Louisville, Kentucky, USA.<br /><searchLink fieldCode="AU" term="%22Quach+H%22">Quach H</searchLink>; University of Melbourne, St. Vincent's Hospital, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Jagannath+S%22">Jagannath S</searchLink>; Icahn School of Medicine at Mount Sinai Tisch Cancer Institute, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Moreau+P%22">Moreau P</searchLink>; University Hospital, Hotel-Dieu, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Levy+M%22">Levy M</searchLink>; Baylor University Medical Center, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Badros+A%22">Badros A</searchLink>; University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Anderson+LD+Jr%22">Anderson LD Jr</searchLink>; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Bahlis+NJ%22">Bahlis NJ</searchLink>; University of Calgary, Charbonneau Cancer Research Institute, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Facon+T%22">Facon T</searchLink>; CHU Lille Service des Maladies du Sang F-59000, Lille, France.<br /><searchLink fieldCode="AU" term="%22Mateos+MV%22">Mateos MV</searchLink>; Hospital Universitario de Salamanca, Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Cavo+M%22">Cavo M</searchLink>; Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Chang+H%22">Chang H</searchLink>; Karyopharm Therapeutics Inc., Newton, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Landesman+Y%22">Landesman Y</searchLink>; Karyopharm Therapeutics Inc., Newton, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Chai+Y%22">Chai Y</searchLink>; Karyopharm Therapeutics Inc., Newton, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Arazy+M%22">Arazy M</searchLink>; Karyopharm Therapeutics Inc., Newton, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Shah+J%22">Shah J</searchLink>; Karyopharm Therapeutics Inc., Newton, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Shacham+S%22">Shacham S</searchLink>; Karyopharm Therapeutics Inc., Newton, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Kauffman+MG%22">Kauffman MG</searchLink>; Karyopharm Therapeutics Inc., Newton, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Grosicki+S%22">Grosicki S</searchLink>; Medical University of Silesia, Katowice, Poland.<br /><searchLink fieldCode="AU" term="%22Richardson+PG%22">Richardson PG</searchLink>; Dana Farber Cancer Institute, Boston, Massachusetts, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227610369%22">American journal of hematology</searchLink> [Am J Hematol] 2021 Sep 01; Vol. 96 (9), pp. 1120-1130. <i>Date of Electronic Publication: </i>2021 Jul 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7610369 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1096-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203618609%22">03618609 </searchLink><i>NLM ISO Abbreviation: </i>Am J Hematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34062004
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/ajh.26261
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1120
    Titles:
      – TitleFull: Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Richard S
      – PersonEntity:
          Name:
            NameFull: Chari A
      – PersonEntity:
          Name:
            NameFull: Delimpasi S
      – PersonEntity:
          Name:
            NameFull: Simonova M
      – PersonEntity:
          Name:
            NameFull: Spicka I
      – PersonEntity:
          Name:
            NameFull: Pour L
      – PersonEntity:
          Name:
            NameFull: Kriachok I
      – PersonEntity:
          Name:
            NameFull: Dimopoulos MA
      – PersonEntity:
          Name:
            NameFull: Pylypenko H
      – PersonEntity:
          Name:
            NameFull: Auner HW
      – PersonEntity:
          Name:
            NameFull: Leleu X
      – PersonEntity:
          Name:
            NameFull: Usenko G
      – PersonEntity:
          Name:
            NameFull: Hajek R
      – PersonEntity:
          Name:
            NameFull: Benjamin R
      – PersonEntity:
          Name:
            NameFull: Dolai TK
      – PersonEntity:
          Name:
            NameFull: Sinha DK
      – PersonEntity:
          Name:
            NameFull: Venner CP
      – PersonEntity:
          Name:
            NameFull: Garg M
      – PersonEntity:
          Name:
            NameFull: Stevens DA
      – PersonEntity:
          Name:
            NameFull: Quach H
      – PersonEntity:
          Name:
            NameFull: Jagannath S
      – PersonEntity:
          Name:
            NameFull: Moreau P
      – PersonEntity:
          Name:
            NameFull: Levy M
      – PersonEntity:
          Name:
            NameFull: Badros A
      – PersonEntity:
          Name:
            NameFull: Anderson LD Jr
      – PersonEntity:
          Name:
            NameFull: Bahlis NJ
      – PersonEntity:
          Name:
            NameFull: Facon T
      – PersonEntity:
          Name:
            NameFull: Mateos MV
      – PersonEntity:
          Name:
            NameFull: Cavo M
      – PersonEntity:
          Name:
            NameFull: Chang H
      – PersonEntity:
          Name:
            NameFull: Landesman Y
      – PersonEntity:
          Name:
            NameFull: Chai Y
      – PersonEntity:
          Name:
            NameFull: Arazy M
      – PersonEntity:
          Name:
            NameFull: Shah J
      – PersonEntity:
          Name:
            NameFull: Shacham S
      – PersonEntity:
          Name:
            NameFull: Kauffman MG
      – PersonEntity:
          Name:
            NameFull: Grosicki S
      – PersonEntity:
          Name:
            NameFull: Richardson PG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2021 Sep 01
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1096-8652
          Numbering:
            – Type: volume
              Value: 96
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: American journal of hematology
              Type: main
ResultId 1